Abstract
Many human diseases, including cardiovascular disease, show differences between men and women in pathology and treatment outcomes. In the case of cardiac disease, sex differences are exemplified by differences in the frequency of specific types of congenital and adult-onset heart disease. Clinical studies have suggested that gonadal hormones are a factor in sex bias. However, recent research has shown that gene and protein networks under non-hormonal control also account for cardiac sex differences. In this Review, we describe the sex-chromosome pathways that lead to sex differences in the development and function of the heart and highlight how these findings affect future care and treatment of cardiac disease.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 digital issues and online access to articles
$119.00 per year
only $9.92 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Deegan, D. F., Nigam, P. & Engel, N. Sexual dimorphism of the heart: genetics, epigenetics, and development. Front. Cardiovasc. Med. 8, 668252 (2021).
Prabhavathi, K., Selvi, K. T., Poornima, K. N. & Sarvanan, A. Role of biological sex in normal cardiac function and in its disease outcome — a review. J. Clin. Diagn. Res. 8, BE01–BE04 (2014).
Kerkhof, P. L. M. et al. Heart function analysis in cardiac patients with focus on sex-specific aspects. Adv. Exp. Med. Biol. 1065, 361–377 (2018).
Siokatas, G. et al. Sex-related effects on cardiac development and disease. J. Cardiovasc. Dev. Dis. 9, 90 (2022).
Ruiz-Meana, M. et al. Ageing, sex, and cardioprotection. Br. J. Pharmacol. 177, 5270–5286 (2020).
Luczak, E. D. & Leinwand, L. A. Sex-based cardiac physiology. Annu. Rev. Physiol. 71, 1–18 (2009).
Reue, K. & Wiese, C. B. Illuminating the mechanisms underlying sex differences in cardiovascular disease. Circ. Res. 130, 1747–1762 (2022).
Senyo, S. E., Lee, R. T. & Kuhn, B. Cardiac regeneration based on mechanisms of cardiomyocyte proliferation and differentiation. Stem Cell Res. 13, 532–541 (2014).
Biondi-Zoccai, G. G. et al. Incidence, predictors, and outcomes of coronary dissections left untreated after drug-eluting stent implantation. Eur. Heart J. 27, 540–546 (2006).
Parks, R. J. & Howlett, S. E. Sex differences in mechanisms of cardiac excitation–contraction coupling. Pflugers Arch. 465, 747–763 (2013).
Trexler, C. L., Odell, A. T., Jeong, M. Y., Dowell, R. D. & Leinwand, L. A. Transcriptome and functional profile of cardiac myocytes is influenced by biological sex. Circ. Cardiovasc. Genet. 10, e001770 (2017). This study defined fundamental biological and physiological differences in myocytes derived from male and female rats.
Gaborit, N. et al. Gender-related differences in ion-channel and transporter subunit expression in non-diseased human hearts. J. Mol. Cell. Cardiol. 49, 639–646 (2010). This paper demonstrates significant differences in the expression of components of the cardiac ion channel in non-diseased human hearts.
Shi, W. et al. Cardiac proteomics reveals sex chromosome-dependent differences between males and females that arise prior to gonad formation. Dev. Cell 56, 3019–3034 (2021). This work demonstrates that cardiac sex differences are established in an X-linked gene dosage and are propagated by post-transcriptional mechanisms prior to the expression of Sry.
Macfarlane, P. W. The influence of age and sex on the electrocardiogram. Adv. Exp. Med. Biol. 1065, 93–106 (2018).
James, A. F., Choisy, S. C. & Hancox, J. C. Recent advances in understanding sex differences in cardiac repolarization. Prog. Biophys. Mol. Biol. 94, 265–319 (2007).
Ravens, U. Sex differences in cardiac electrophysiology. Can. J. Physiol. Pharmacol. 96, 985–990 (2018).
Yoo, B. W. Epidemiology of congenital heart disease with emphasis on sex-related aspects. Adv. Exp. Med. Biol. 1065, 49–59 (2018).
Yusifov, A., Woulfe, K. C. & Bruns, D. R. Mechanisms and implications of sex differences in cardiac aging. J. Cardiovasc. Aging 2, 20 (2022).
Claessens, T. E. et al. Noninvasive assessment of left ventricular and myocardial contractility in middle-aged men and women: disparate evolution above the age of 50? Am. J. Physiol. Heart Circ. Physiol. 292, H856–H865 (2007).
Yusifov, A. et al. Transcriptomic analysis of cardiac gene expression across the life course in male and female mice. Physiol. Rep. 9, e14940 (2021).
Cheitlin, M. D. Cardiovascular physiology—changes with aging. Am. J. Geriatr. Cardiol. 12, 9–13 (2003).
Grilo, G. A. et al. Age- and sex-dependent differences in extracellular matrix metabolism associate with cardiac functional and structural changes. J. Mol. Cell. Cardiol. 139, 62–74 (2020).
Achkar, A., Saliba, Y. & Fares, N. Differential gender-dependent patterns of cardiac fibrosis and fibroblast phenotypes in aging mice. Oxid. Med. Cell Longev. 2020, 8282157 (2020).
Kessler, E. L., Rivaud, M. R., Vos, M. A. & van Veen, T. A. B. Sex-specific influence on cardiac structural remodeling and therapy in cardiovascular disease. Biol. Sex Differ. 10, 7 (2019).
Egbe, A. et al. Incidences and sociodemographics of specific congenital heart diseases in the United States of America: an evaluation of hospital discharge diagnoses. Pediatr. Cardiol. 35, 975–982 (2014). A statistical study demonstrating sex-biased congenital heart disease in a large representative population of patients in the United States.
Rothman, K. J. & Fyler, D. C. Sex, birth order, and maternal age characteristics of infants with congenital heart defects. Am. J. Epidemiol. 104, 527–534 (1976). Analyses of children in the New England Regional Infant Cardiac Program reveal sex-differential risk trends in congenital heart disease between males versus females.
Tennant, P. W., Samarasekera, S. D., Pless-Mulloli, T. & Rankin, J. Sex differences in the prevalence of congenital anomalies: a population-based study. Birth Defects Res. A Clin. Mol. Teratol. 91, 894–901 (2011).
Shaw, G. M., Carmichael, S. L., Kaidarova, Z. & Harris, J. A. Differential risks to males and females for congenital malformations among 2.5 million California births, 1989–1997. Birth Defects Res. A Clin. Mol. Teratol. 67, 953–958 (2003).
Michalski, A. M. et al. Sex ratios among infants with birth defects, National Birth Defects Prevention Study, 1997–2009. Am. J. Med. Genet. A 167A, 1071–1081 (2015).
Maric-Bilkan, C. et al. Report of the National Heart, Lung, and Blood Institute Working Group on Sex Differences Research in Cardiovascular Disease: scientific questions and challenges. Hypertension 67, 802–807 (2016). Recommendations from the Report of the National Heart, Lung, and Blood Institute Working Group on how to address sex differences in research of cardiovascular disease.
Giannakoulas, G. et al. Adult congenital heart disease in Greece: preliminary data from the CHALLENGE registry. Int. J. Cardiol. 245, 109–113 (2017).
Arnold, A. L., Milner, K. A. & Vaccarino, V. Sex and race differences in electrocardiogram use (the National Hospital Ambulatory Medical Care Survey). Am. J. Cardiol. 88, 1037–1040 (2001).
Khan, S. S., Beach, L. B. & Yancy, C. W. Sex-based differences in heart failure: JACC Focus Seminar 7/7. J. Am. Coll. Cardiol. 79, 1530–1541 (2022).
Lala, A. et al. Sex differences in heart failure. J. Card. Fail. 28, 477–498 (2022).
Regitz-Zagrosek, V. & Kararigas, G. Mechanistic pathways of sex differences in cardiovascular disease. Physiol. Rev. 97, 1–37 (2017).
Gerdts, E. & Regitz-Zagrosek, V. Sex differences in cardiometabolic disorders. Nat. Med. 25, 1657–1666 (2019).
Waheed, N. et al. Sex differences in non-obstructive coronary artery disease. Cardiovasc Res 116, 829–840 (2020).
Shufelt, C. L., Pacheco, C., Tweet, M. S. & Miller, V. M. Sex-specific physiology and cardiovascular disease. Adv. Exp. Med. Biol. 1065, 433–454 (2018).
Kong, W. K. F., Bax, J. J., Michelena, H. I. & Delgado, V. Sex differences in bicuspid aortic valve disease. Prog. Cardiovasc. Dis. 63, 452–456 (2020).
Pelliccia, F. et al. Sex-related differences in cardiomyopathies. Int. J. Cardiol. 286, 239–243 (2019).
Humphries, K. H. et al. Sex differences in cardiovascular disease — impact on care and outcomes. Front. Neuroendocrinol. 46, 46–70 (2017).
Summerhill, V. I., Moschetta, D., Orekhov, A. N., Poggio, P. & Myasoedova, V. A. Sex-specific features of calcific aortic valve disease. Int. J. Mol. Sci. 21, 5620 (2020).
Hoppe, B. L. & Hermann, D. D. Sex differences in the causes and natural history of heart failure. Curr. Cardiol. Rep. 5, 193–199 (2003).
Stock, E. O. & Redberg, R. Cardiovascular disease in women. Curr. Probl. Cardiol. 37, 450–526 (2012).
Woodward, M. Rationale and tutorial for analysing and reporting sex differences in cardiovascular associations. Heart 105, 1701–1708 (2019).
Elhmidi, Y. et al. Sex-related differences in 2197 patients undergoing isolated surgical aortic valve replacement. J. Card. Surg. 29, 772–778 (2014).
Regitz-Zagrosek, V. & Seeland, U. Sex and gender differences in myocardial hypertrophy and heart failure. Wien Med. Wochenschr. 161, 109–116 (2011).
Blenck, C. L., Harvey, P. A., Reckelhoff, J. F. & Leinwand, L. A. The importance of biological sex and estrogen in rodent models of cardiovascular health and disease. Circ. Res. 118, 1294–1312 (2016).
Ventura-Clapier, R. et al. Sex in basic research: concepts in the cardiovascular field. Cardiovasc. Res. 113, 711–724 (2017).
Kararigas, G. et al. Sex-dependent regulation of fibrosis and inflammation in human left ventricular remodelling under pressure overload. Eur. J. Heart Fail. 16, 1160–1167 (2014).
Wu, J., Dai, F., Li, C. & Zou, Y. Gender differences in cardiac hypertrophy. J. Cardiovasc. Transl. Res. 13, 73–84 (2019).
Patrizio, M. & Marano, G. Gender differences in cardiac hypertrophic remodeling. Ann. Ist. Super. Sanita 52, 223–229 (2016).
Chester, R. C., Kling, J. M. & Manson, J. E. What the Women’s Health Initiative has taught us about menopausal hormone therapy. Clin. Cardiol. 41, 247–252 (2018).
Chlebowski, R. T. et al. Estrogen alone and health outcomes in black women by African ancestry: a secondary analyses of a randomized controlled trial. Menopause 24, 133–141 (2017).
Whayne, T. F.Jr & Mukherjee, D. Women, the menopause, hormone replacement therapy and coronary heart disease. Curr. Opin. Cardiol. 30, 432–438 (2015).
Mosca, L. et al. Evidence-based guidelines for cardiovascular disease prevention in women: 2007 update. J. Am. Coll. Cardiol. 49, 1230–1250 (2007).
Naqvi, S. et al. Conservation, acquisition, and functional impact of sex-biased gene expression in mammals. Science 365, eaaw7317 (2019).
Arnold, A. P. Rethinking sex determination of non-gonadal tissues. Curr. Top. Dev. Biol. 134, 289–315 (2019).
Snell, D. M. & Turner, J. M. A. Sex chromosome effects on male–female differences in mammals. Curr. Biol. 28, R1313–R1324 (2018).
DeLeon-Pennell, K. Y. & Lindsey, M. L. Somewhere over the sex differences rainbow of myocardial infarction remodeling: hormones, chromosomes, inflammasome, oh my. Expert Rev. Proteomics 16, 933–940 (2019).
Tingen, C. M., Kim, A. M., Wu, P. H. & Woodruff, T. K. Sex and sensitivity: the continued need for sex-based biomedical research and implementation. Womens Health 6, 511–516 (2010).
Kim, A. M., Tingen, C. M. & Woodruff, T. K. Sex bias in trials and treatment must end. Nature 465, 688–689 (2010).
Baylis, F. & Kaposky, C. Wanted: inclusive guidelines for research involving pregnant women. J. Obstet. Gynaecol. Can. 32, 473–476 (2010).
Harris, D. J. & Douglas, P. S. Enrollment of women in cardiovascular clinical trials funded by the National Heart, Lung, and Blood Institute. N. Engl. J. Med. 343, 475–480 (2000).
Parker, K., Erzurumluoglu, A. M. & Rodriguez, S. The Y chromosome: a complex locus for genetic analyses of complex human traits. Genes 11, 1273 (2020).
Hickey, P. F. & Bahlo, M. X chromosome association testing in genome wide association studies. Genet. Epidemiol. 35, 664–670 (2011).
Dimas, A. S. et al. Sex-biased genetic effects on gene regulation in humans. Genome Res. 2, 2368–2375 (2012).
Westerman, S. & Wenger, N. K. Women and heart disease, the underrecognized burden: sex differences, biases, and unmet clinical and research challenges. Clin. Sci. 130, 551–563 (2016).
Noubiap, J. J. et al. Sex disparities in enrollment and reporting of outcomes by sex in contemporary clinical trials of atrial fibrillation. J. Cardiovasc. Electrophysiol. 33, 845–854 (2022).
Woodward, M. Cardiovascular disease and the female disadvantage. Int. J. Environ. Res. Public Health 16, 1165 (2019).
Mayne, B. T. et al. Large scale gene expression meta-analysis reveals tissue-specific, sex-biased gene expression in humans. Front. Genet. 7, 183 (2016).
Isensee, J. et al. Sexually dimorphic gene expression in the heart of mice and men. J. Mol. Med. 86, 61–74 (2008). A refined study comparing gene expression profiling of mouse and human cardiac samples of male versus female in young and aged individuals.
Li, B. et al. A comprehensive mouse transcriptomic BodyMap across 17 tissues by RNA-seq. Sci. Rep. 7, 4200 (2017).
Lopes-Ramos, C. M. et al. Sex differences in gene expression and regulatory networks across 29 human tissues. Cell Rep. 31, 107795 (2020).
Tsuji, M. et al. Sexual dimorphisms of mRNA and miRNA in human/murine heart disease. PLoS ONE 12, e0177988 (2017).
InanlooRahatloo, K. et al. Sex-based differences in myocardial gene expression in recently deceased organ donors with no prior cardiovascular disease. PLoS ONE 12, e0183874 (2017). This study identified male versus female gene expression differences in non-diseased human heart samples.
Dorr, K. M. & Conlon, F. L. Proteomic-based approaches to cardiac development and disease. Curr. Opin. Chem. Biol. 48, 150–157 (2019).
Arnold, A. P. The end of gonad-centric sex determination in mammals. Trends Genet. 28, 55–61 (2012).
Capel, B. Vertebrate sex determination: evolutionary plasticity of a fundamental switch. Nat. Rev. Genet. 18, 675–689 (2017). This is an excellent review of gene pathways that cause differentiation of testes or ovaries, emphasizing the surprising variability of regulatory mechanisms across vertebrate species.
Arnold, A. P. X chromosome agents of sexual differentiation. Nat. Rev. Endocrinol. 18, 574–583 (2022). This paper discusses specific genes and a class of genes on the X chromosome that are the root cause of sex differences in tissue phenotypes.
Herber, C. B. et al. Estrogen signaling in arcuate Kiss1 neurons suppresses a sex-dependent female circuit promoting dense strong bones. Nat. Commun. 10, 163 (2019).
Arnold, A. P. The organizational-activational hypothesis as the foundation for a unified theory of sexual differentiation of all mammalian tissues. Horm. Behav. 55, 570–578 (2009).
Burgoyne, P. S. & Arnold, A. P. A primer on the use of mouse models for identifying direct sex chromosome effects that cause sex differences in non-gonadal tissues. Biol. Sex Differ. 7, 68 (2016).
Arnold, A. P. Four Core Genotypes and XY* mouse models: update on impact on SABV research. Neurosci. Biobehav. Rev. 119, 1–8 (2020). This paper gives a background on two major mouse models that are used to discover sex-chromosome effects causing sex differences in mouse models of any disease.
Cox, K. H., Bonthuis, P. J. & Rissman, E. F. Mouse model systems to study sex chromosome genes and behavior: relevance to humans. Front. Neuroendocrinol. 35, 405–419 (2014).
Corre, C. et al. Separate effects of sex hormones and sex chromosomes on brain structure and function revealed by high-resolution magnetic resonance imaging and spatial navigation assessment of the Four Core Genotype mouse model. Brain Struct. Funct. 221, 997–1016 (2016).
Cisternas, C. D., Garcia-Segura, L. M. & Cambiasso, M. J. Hormonal and genetic factors interact to control aromatase expression in the developing brain. J. Neuroendocrinol. 30, e12535 (2018).
Arnold, A. P., Cassis, L. A., Eghbali, M., Reue, K. & Sandberg, K. Sex hormones and sex chromosomes cause sex differences in the development of cardiovascular diseases. Arterioscler. Thromb. Vasc. Biol. 37, 746–756 (2017).
Li, J. et al. The number of X chromosomes influences protection from cardiac ischaemia/reperfusion injury in mice: one X is better than two. Cardiovasc. Res. 102, 375–394 (2014).
Cunningham, C. M. et al. Y-chromosome gene, Uty, protects against pulmonary hypertension by reducing proinflammatory chemokines. Am. J. Respir. Crit. Care Med. 206, 186–196 (2022). This report is remarkable because it implicates a Y-chromosome gene in the control of sex differences in non-reproductive tissue phenotypes and disease, through mechanisms that do not involve gonadal hormones.
AlSiraj, Y. et al. XX sex chromosome complement promotes atherosclerosis in mice. Nat. Commun. 10, 2631 (2019).
Alsiraj, Y. et al. Female mice with an XY sex chromosome complement develop severe angiotensin II-induced abdominal aortic aneurysms. Circulation 135, 379–391 (2017).
Caeiro, X. E., Mir, F. R., Vivas, L. M., Carrer, H. F. & Cambiasso, M. J. Sex chromosome complement contributes to sex differences in bradycardic baroreflex response. Hypertension 58, 505–511 (2011).
Ji, H. et al. Sex chromosome effects unmasked in angiotensin II-induced hypertension. Hypertension 55, 1275–1282 (2010).
Qi, S. et al. X, but not Y, chromosomal complement contributes to stroke sensitivity in aged animals. Transl. Stroke Res. https://doi.org/10.1007/s12975-022-01070-z (2022).
McCullough, L. D. et al. Stroke sensitivity in the aged: sex chromosome complement vs. gonadal hormones. Aging 8, 1432–1441 (2016). This paper reviews studies suggesting that sex differences in stroke sensitivity are caused by gonadal hormonal mechanisms in young animals, but by sex-chromosomal mechanisms in older animals.
Deegan, D. F. & Engel, N. Sexual dimorphism in the age of genomics: how, when, where. Front. Cell Dev. Biol. 7, 186 (2019).
Viuff, M., Skakkebaek, A., Nielsen, M. M., Chang, S. & Gravholt, C. H. Epigenetics and genomics in Turner syndrome. Am. J. Med. Genet. C Semin. Med. Genet. 181, 68–75 (2019).
Gravholt, C. H., Viuff, M. H., Brun, S., Stochholm, K. & Andersen, N. H. Turner syndrome: mechanisms and management. Nat. Rev. Endocrinol. 15, 601–614 (2019).
Huang, A. C., Olson, S. B. & Maslen, C. L. A review of recent developments in Turner syndrome research. J. Cardiovasc. Dev. Dis. 8, 138 (2021).
Milbrandt, T. & Thomas, E. Turner syndrome. Pediatr. Rev. 34, 420–421 (2013).
Ranke, M. B. & Saenger, P. Turner’s syndrome. Lancet 358, 309–314 (2001).
Mortensen, K. H., Andersen, N. H. & Gravholt, C. H. Cardiovascular phenotype in Turner syndrome—integrating cardiology, genetics, and endocrinology. Endocr. Rev. 33, 677–714 (2012).
Schoemaker, M. J. et al. Mortality in women with turner syndrome in Great Britain: a national cohort study. J. Clin. Endocrinol. Metab. 93, 4735–4742 (2008).
Groth, K. A., Skakkebaek, A., Host, C., Gravholt, C. H. & Bojesen, A. Clinical review: Klinefelter syndrome—a clinical update. J. Clin. Endocrinol. Metab. 98, 20–30 (2013).
Bojesen, A., Juul, S., Birkebaek, N. H. & Gravholt, C. H. Morbidity in Klinefelter syndrome: a Danish register study based on hospital discharge diagnoses. J. Clin. Endocrinol. Metab. 91, 1254–1260 (2006).
Salzano, A. et al. Klinefelter syndrome, cardiovascular system, and thromboembolic disease: review of literature and clinical perspectives. Eur. J. Endocrinol. 175, R27–R40 (2016).
Spaziani, M. & Radicioni, A. F. Metabolic and cardiovascular risk factors in Klinefelter syndrome. Am. J. Med. Genet. C Semin. Med. Genet. 184, 334–343 (2020).
Calogero, A. E. et al. Klinefelter syndrome: cardiovascular abnormalities and metabolic disorders. J. Endocrinol. Invest. 40, 705–712 (2017).
Pasquali, D. et al. Cardiovascular abnormalities in Klinefelter syndrome. Int. J. Cardiol. 168, 754–759 (2013).
Accardo, G. et al. Management of cardiovascular complications in Klinefelter syndrome patients. Expert Rev. Endocrinol. Metab. 14, 145–152 (2019).
Dolk, H., Loane, M. A., Abramsky, L., de Walle, H. & Garne, E. Birth prevalence of congenital heart disease. Epidemiology 21, 275–277 (2010).
Heron, M. et al. Deaths: final data for 2006. Natl. Vital Stat. Rep. 57, 1–134 (2009).
Haberer, K. & Silversides, C. K. Congenital heart disease and women’s health across the life span: focus on reproductive issues. Can. J. Cardiol. 35, 1652–1663 (2019).
Nef, S., Stevant, I. & Greenfield, A. Characterizing the bipotential mammalian gonad. Curr. Top. Dev. Biol. 134, 167–194 (2019).
Garcia-Moreno, S. A., Plebanek, M. P. & Capel, B. Epigenetic regulation of male fate commitment from an initially bipotential system. Mol. Cell. Endocrinol. 468, 19–30 (2018).
Bruneau, B. G. The developing heart and congenital heart defects: a make or break situation. Clin. Genet. 63, 252–261 (2003).
Deegan, D. F., Karbalaei, R., Madzo, J., Kulathinal, R. J. & Engel, N. The developmental origins of sex-biased expression in cardiac development. Biol. Sex Differ. 10, 46 (2019). An elegant study demonstrating sex-biased histone modifications in male versus female embryonic stem cells.
Fairweather, D. et al. Sex and gender differences in myocarditis and dilated cardiomyopathy: an update. Front. Cardiovasc. Med. 10, 1129348 (2023).
Han, Y. et al. Proteogenomics reveals sex biased aging genes and coordinated splicing in cardiac aging. Am. J. Physiol. Heart Circ. Physiol. 323, H538–H558 (2022).
Virani, S. S. et al. Heart Disease and Stroke Statistics—2020 Update: a report from the american heart association. Circulation 141, e139–e596 (2020).
Canto, J. G. et al. Association of age and sex with myocardial infarction symptom presentation and in-hospital mortality. J. Am. Med. Assoc. 307, 813–822 (2012).
Pullen, A. B., Kain, V., Serhan, C. N. & Halade, G. V. Molecular and cellular differences in cardiac repair of male and female mice. J. Am. Heart Assoc. 9, e015672 (2020).
Chick, J. M. et al. Defining the consequences of genetic variation on a proteome-wide scale. Nature 534, 500–505 (2016).
Sano, S. et al. Hematopoietic loss of Y chromosome leads to cardiac fibrosis and heart failure mortality. Science 377, 292–297 (2022).
Aguado, B. A. et al. Genes that escape X chromosome inactivation modulate sex differences in valve myofibroblasts. Circulation 145, 513–530 (2022).
Wu, H. et al. Cellular resolution maps of X chromosome inactivation: implications for neural development, function, and disease. Neuron 81, 103–119 (2014).
Disteche, C. M. & Berletch, J. B. X-chromosome inactivation and escape. J. Genet. 94, 591–599 (2015).
Peeters, S. B. et al. How do genes that escape from X-chromosome inactivation contribute to Turner syndrome? Am. J. Med. Genet. C Semin. Med. Genet. 181, 28–35 (2019).
Sierra, I. & Anguera, M. C. Enjoy the silence: X-chromosome inactivation diversity in somatic cells. Curr. Opin. Genet. Dev. 55, 26–31 (2019).
Harris, J. C. et al. The Cstf2t polyadenylation gene plays a sex-specific role in learning behaviors in mice. PLoS ONE 11, e0165976 (2016).
Davuluri, R. V., Suzuki, Y., Sugano, S., Plass, C. & Huang, T. H. The functional consequences of alternative promoter use in mammalian genomes. Trends Genet. 24, 167–177 (2008).
De Gobbi, M. et al. A regulatory SNP causes a human genetic disease by creating a new transcriptional promoter. Science 312, 1215–1217 (2006).
Elkon, R., Ugalde, A. P. & Agami, R. Alternative cleavage and polyadenylation: extent, regulation and function. Nat. Rev. Genet. 14, 496–506 (2013).
Tian, B. & Manley, J. L. Alternative polyadenylation of mRNA precursors. Nat. Rev. Mol. Cell Biol. 18, 18–30 (2017).
Creemers, E. E. et al. Genome-wide polyadenylation maps reveal dynamic mRNA 3′-end formation in the failing human heart. Circ. Res. 118, 433–438 (2016).
Adiconis, X. et al. Comprehensive comparative analysis of 5′-end RNA-sequencing methods. Nat. Methods 15, 505–511 (2018).
Murata, M. et al. Detecting expressed genes using CAGE. Methods Mol. Biol. 1164, 67–85 (2014).
Routh, A., Head, S. R., Ordoukhanian, P. & Johnson, J. E. ClickSeq: fragmentation-free next-generation sequencing via click ligation of adaptors to stochastically terminated 3′-azido cDNAs. J. Mol. Biol. 427, 2610–2616 (2015).
Elrod, N. D., Jaworski, E. A., Ji, P., Wagner, E. J. & Routh, A. Development of Poly(A)-ClickSeq as a tool enabling simultaneous genome-wide poly(A)-site identification and differential expression analysis. Methods 155, 20–29 (2019).
Newman, M. S., Nguyen, T., Watson, M. J., Hull, R. W. & Yu, H. G. Transcriptome profiling reveals novel BMI- and sex-specific gene expression signatures for human cardiac hypertrophy. Physiol. Genomics 49, 355–367 (2017).
Fermin, D. R. et al. Sex and age dimorphism of myocardial gene expression in nonischemic human heart failure. Circ. Cardiovasc. Genet. 1, 117–125 (2008).
Collins, F. S. & Tabak, L. A. Policy: NIH plans to enhance reproducibility. Nature 505, 612–613 (2014).
Arnegard, M. E., Whitten, L. A., Hunter, C. & Clayton, J. A. Sex as a biological variable: a 5-year progress report and call to action. J. Womens Health 29, 858–864 (2020).
Geller, S. E. et al. A global view of severe maternal morbidity: moving beyond maternal mortality. Reprod. Health 15, 98 (2018).
Li, J. et al. The number of X chromosomes influences protection from cardiac ischaemia/reperfusion injury in mice: one X is better than two. Cardiovasc. Res. 102, 375–384 (2014).
Chen, X. et al. The number of x chromosomes causes sex differences in adiposity in mice. PLoS Genet. 8, e1002709 (2012).
Umar, S. et al. The Y chromosome plays a protective role in experimental hypoxic pulmonary hypertension. Am. J. Respir. Crit. Care Med. 197, 952–955 (2018).
Link, J. C. et al. X chromosome dosage of histone demethylase KDM5C determines sex differences in adiposity. J. Clin. Invest. 130, 5688–5702 (2020).
Acknowledgements
We thank the members of the Conlon Lab for editing and proofing and A. Scialdone for her help with editing. We thank the three reviewers for contributing to the external peer review. We regret that we could not recognize all pertinent research in the field and contributions from investigators owing to space constraints. This work was supported by the grants R01HL156424 NIH/NHLBI to F.L.C. A.P.A. was supported by OD030496, HD1002989, HL131182 and DK083561.
Author information
Authors and Affiliations
Contributions
F.L.C. and A.P.A. wrote and edited the manuscript.
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing interests.
Peer review
Peer review information
Nature Cardiovascular Research thanks Christine M. Disteche, C. Noel Bairey Merz and the other, anonymous, reviewer(s) for their contribution to the peer review of this work.
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Conlon, F.L., Arnold, A.P. Sex-chromosome mechanisms in cardiac development and disease. Nat Cardiovasc Res 2, 340–350 (2023). https://doi.org/10.1038/s44161-023-00256-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/s44161-023-00256-4
This article is cited by
-
Disruption of the Uty epigenetic regulator locus in hematopoietic cells phenocopies the profibrotic attributes of Y chromosome loss in heart failure
Nature Cardiovascular Research (2024)